BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hepatitis
,
Leukocyte
,
Early pregnancy factor
,
Acetaminophen
,
rs4950928
,
TGFB1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
mrna decay
Summary
General Info
Curated Studies
Most Correlated Studies
mRNA decay in MDA-MB-231 cells transfected with HNRPA2B1 siRNA
Nonsense-mediated mRNA decay-inhibited LCLs from families predisposed to breast cancer
Embryonic kidney 293 cells with silenced nonsense-mediated mRNA decay factors PTBP1 and UPF1
RNA decay rates in lymphoblastoid cell lines
Granulocytes treated with caffeine to inhibit nonsense-mediated decay
Explore Curated Studies Results
Literature
Most Relevant Literature
Cytoplasmic organelles on the road to mRNA decay.
mRNAStab--a web application for mRNA stability analysis.
Global analysis of mRNA stability in Mycobacterium tuberculosis.
RNA decay via 3' uridylation.
RNA processing and decay in plastids.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Na+ Channel mRNA Regulation in Heart Failure
A Study of Hypoxia-inducible Factor 1a (HIF1A) Messenger Ribonucleic Acid (mRNA) Antagonist (RO70701…
Correction of Nonsense Mutations in Cystic Fibrosis
Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( …
Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ